Compare OSS & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OSS | TKNO |
|---|---|---|
| Founded | 1998 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.3M | 214.1M |
| IPO Year | 2018 | 2021 |
| Metric | OSS | TKNO |
|---|---|---|
| Price | $9.45 | $2.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 3.1M | 361.8K |
| Earning Date | 03-18-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $60,264,017.00 | $39,801,000.00 |
| Revenue This Year | N/A | $8.64 |
| Revenue Next Year | N/A | $9.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.33 | 9.50 |
| 52 Week Low | $1.85 | $1.96 |
| 52 Week High | $12.75 | $9.69 |
| Indicator | OSS | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 50.60 | 17.00 |
| Support Level | $7.96 | $1.96 |
| Resistance Level | $11.09 | $2.54 |
| Average True Range (ATR) | 0.90 | 0.27 |
| MACD | -0.22 | -0.04 |
| Stochastic Oscillator | 43.71 | 12.69 |
One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bressner segment.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.